Antibodies to myelin don't predict progression to multiple sclerosisBMJ 2007; 334 doi: https://doi.org/10.1136/bmj.334.7587.231-a (Published 01 February 2007) Cite this as: BMJ 2007;334:231
It's hard to predict what will happen to patients who present with a first neurological episode suggestive of multiple sclerosis. Some will recover, whereas others will progress to the full blown clinical disease. An accurate prognostic test would be a real benefit to …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial